Figure 1.

Figure 1.

Individual cerebrospinal fluid (CSF) glucosylsphingosine (GluSph) log2-fold changes from baseline after 90 days of dosing with rexaceract

Format

PNG

Source

Gain Therapeutics, Inc.

Downloads